Novel antiviral strategies targeting methyltransferases, RIPK2, and STING pathway

0578953 - ÚOCHB 2024 RIV CZ eng A - Abstrakt
Dejmek, Milan - Štefek, Milan - Otava, Tomáš - Misehe, Mbilo - Krafčíková, Petra - Klíma, Martin - Šála, Michal - Břehová, Petra - Bouřa, Evžen - Nencka, Radim
Novel antiviral strategies targeting methyltransferases, RIPK2, and STING pathway.
Czech Chemical Society Symposium Series. Roč. 21, č. 5 (2023), s. 182. ISSN 2336-7202.
[Annual meeting of the National Institute of Virology and Bacteriology (NIVB) /2./. 02.10.2023-05.10.2023, Kutná Hora]
Grant CEP: GA MŠMT(CZ) LX22NPO5103
Institucionální podpora: RVO:61388963
Klíčová slova: methylstransferases * RIPK2 inhibitors * STING
Obor OECD: Virology
http://www.ccsss.cz/index.php/ccsss/issue/view/41/75

Our group's research over the past year has been focused primarily on the medicinal chemistry of novel antivirals, with a major emphasis on three separate topics - inhibitors of viral methyltransferases, inhibitors of human RIPK2 as a host factor implicated in replication of various viruses, and STING agonists.
Trvalý link: https://hdl.handle.net/11104/0347856